{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:41:11Z","timestamp":1794030071208,"version":"4.8.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,2,3]],"date-time":"2015-02-03T00:00:00Z","timestamp":1422921600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2015,2,3]],"date-time":"2015-02-03T00:00:00Z","timestamp":1422921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/srep08096","type":"journal-article","created":{"date-parts":[[2015,2,3]],"date-time":"2015-02-03T05:29:48Z","timestamp":1422941388000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":553,"title":["Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease"],"prefix":"10.1038","volume":"5","author":[{"given":"Weiwei","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyun","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,3]]},"reference":[{"key":"BFsrep08096_CR1","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.cgh.2012.03.011","volume":"10","author":"DM Torres","year":"2012","unstructured":"Torres, D. M., Williams, C. D. & Harrison, S. A. Features, diagnosis and treatment of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 10, 837\u2013858 (2012).","journal-title":"Clin Gastroenterol Hepatol"},{"key":"BFsrep08096_CR2","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/hep.24001","volume":"52","author":"H Tilg","year":"2010","unstructured":"Tilg, H. & Moschen, A. R. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 52, 1836\u20131846 (2010).","journal-title":"Hepatology"},{"key":"BFsrep08096_CR3","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/nrgastro.2010.172","volume":"7","author":"A Abu-Shanab","year":"2010","unstructured":"Abu-Shanab, A. & Quigley, E. M. The role of the gut microbiota in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 7, 691\u2013701 (2010).","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"BFsrep08096_CR4","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.tem.2013.05.009","volume":"24","author":"AR Moschen","year":"2013","unstructured":"Moschen, A. R., Kaser, S. & Tilg, H. Non-alcoholic steatohepatitis: a microbiota-driven disease. Trends Endocrinol Metab 24, 537\u2013545 (2013).","journal-title":"Trends Endocrinol Metab"},{"key":"BFsrep08096_CR5","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/nature05414","volume":"444","author":"PJ Turnbaugh","year":"2006","unstructured":"Turnbaugh, P. J. et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027\u20131031 (2006).","journal-title":"Nature"},{"key":"BFsrep08096_CR6","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1136\/gutjnl-2012-303816","volume":"62","author":"T Le Roy","year":"2013","unstructured":"Le Roy, T. et al. Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. Gut 62, 1787\u20131794 (2013).","journal-title":"Gut"},{"key":"BFsrep08096_CR7","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1126\/science.1223490","volume":"336","author":"LV Hooper","year":"2012","unstructured":"Hooper, L. V., Littman, D. R. & Macpherson, A. J. Interactions between the microbiota and the immune system. Science 336, 1268\u20131273 (2012).","journal-title":"Science"},{"key":"BFsrep08096_CR8","first-page":"306","volume":"125","author":"L Su","year":"2012","unstructured":"Su, L. et al. Intestinal immune barrier integrity in rats with nonalcoholic hepatic steatosis and steatohepatitis. Chin Med J (Engl) 125, 306\u2013311 (2012).","journal-title":"Chin Med J (Engl)"},{"issue":"7","key":"BFsrep08096_CR9","doi-asserted-by":"publisher","first-page":"868-875.e3","DOI":"10.1016\/j.cgh.2013.02.015","volume":"11","author":"Maitreyi Raman","year":"2013","unstructured":"Raman, M. et al. Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 11, 868\u2013875 e861\u2013863 (2013).","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"BFsrep08096_CR10","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/hep.26319","volume":"58","author":"M Mouzaki","year":"2013","unstructured":"Mouzaki, M. et al. Intestinal microbiota in patients with nonalcoholic fatty liver disease. Hepatology 58, 120\u2013127 (2013).","journal-title":"Hepatology"},{"key":"BFsrep08096_CR11","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/hep.26093","volume":"57","author":"L Zhu","year":"2013","unstructured":"Zhu, L. et al. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology 57, 601\u2013609 (2013).","journal-title":"Hepatology"},{"key":"BFsrep08096_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2010\/453563","volume":"2010","author":"G Son","year":"2010","unstructured":"Son, G., Kremer, M. & Hines, I. N. Contribution of gut bacteria to liver pathobiology. Gastroenterol Res Pract 2010, 1\u201313 (2010).","journal-title":"Gastroenterol Res Pract"},{"key":"BFsrep08096_CR13","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.numecd.2012.02.007","volume":"22","author":"D Compare","year":"2012","unstructured":"Compare, D. et al. Gut--liver axis: the impact of gut microbiota on non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 22, 471\u2013476 (2012).","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"BFsrep08096_CR14","doi-asserted-by":"publisher","first-page":"5314","DOI":"10.2174\/1381612811319290011","volume":"19","author":"L Miele","year":"2013","unstructured":"Miele, L. et al. Gut-liver axis and microbiota in NAFLD: insight pathophysiology for novel therapeutic target. Curr Pharm Des 19, 5314\u20135324 (2013).","journal-title":"Curr Pharm Des"},{"key":"BFsrep08096_CR15","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/dmrr.2518","volume":"30","author":"F Fallucca","year":"2014","unstructured":"Fallucca, F., Porrata, C., Fallucca, S. & Pianesi, M. Influence of diet on gut microbiota, inflammation and type 2 diabetes mellitus. First experience with macrobiotic Ma-Pi 2 diet. Diabetes Metab Res Rev 30 Suppl 1, 48\u201354 (2014).","journal-title":"Diabetes Metab Res Rev"},{"key":"BFsrep08096_CR16","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1136\/gut.2008.165886","volume":"58","author":"PD Cani","year":"2009","unstructured":"Cani, P. D. et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58, 1091\u20131103 (2009).","journal-title":"Gut"},{"key":"BFsrep08096_CR17","doi-asserted-by":"publisher","first-page":"279","DOI":"10.4161\/gmic.19625","volume":"3","author":"PD Cani","year":"2012","unstructured":"Cani, P. D., Osto, M., Geurts, L. & Everard, A. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes 3, 279\u2013288 (2012).","journal-title":"Gut Microbes"},{"key":"BFsrep08096_CR18","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1038\/ncomms2957","volume":"4","author":"CL Small","year":"2013","unstructured":"Small, C. L., Reid-Yu, S. A., McPhee, J. B. & Coombes, B. K. Persistent infection with Crohn's disease-associated adherent-invasive Escherichia coli leads to chronic inflammation and intestinal fibrosis. Nat Commun 4, 1957 (2013).","journal-title":"Nat Commun"},{"key":"BFsrep08096_CR19","doi-asserted-by":"publisher","first-page":"11537","DOI":"10.1073\/pnas.1001261107","volume":"107","author":"G Cuevas-Ramos","year":"2010","unstructured":"Cuevas-Ramos, G. et al. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc Natl Acad Sci U S A 107, 11537\u201311542 (2010).","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFsrep08096_CR20","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1136\/gutjnl-2013-304739","volume":"63","author":"M Prorok-Hamon","year":"2014","unstructured":"Prorok-Hamon, M. et al. Colonic mucosa-associated diffusely adherent afaC+ Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancer. Gut 63, 761\u2013770 (2014).","journal-title":"Gut"},{"key":"BFsrep08096_CR21","first-page":"1765","volume":"11","author":"K Al-Jashamy","year":"2010","unstructured":"Al-Jashamy, K., Murad, A., Zeehaida, M., Rohaini, M. & Hasnan, J. Prevalence of colorectal cancer associated with Streptococcus bovis among inflammatory bowel and chronic gastrointestinal tract disease patients. Asian Pac J Cancer Prev 11, 1765\u20131768 (2010).","journal-title":"Asian Pac J Cancer Prev"},{"key":"BFsrep08096_CR22","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1159\/000228558","volume":"27","author":"S Cucchiara","year":"2009","unstructured":"Cucchiara, S., Iebba, V., Conte, M. P. & Schippa, S. The microbiota in inflammatory bowel disease in different age groups. Dig Dis 27, 252\u2013258 (2009).","journal-title":"Dig Dis"},{"key":"BFsrep08096_CR23","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/00075197-200409000-00009","volume":"7","author":"W Scheppach","year":"2004","unstructured":"Scheppach, W. & Weiler, F. The butyrate story: old wine in new bottles? Curr Opin Clin Nutr Metab Care 7, 563\u2013567 (2004).","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"BFsrep08096_CR24","doi-asserted-by":"publisher","first-page":"S100","DOI":"10.1053\/j.gastro.2005.11.048","volume":"130","author":"KA Kles","year":"2006","unstructured":"Kles, K. A. & Chang, E. B. Short-chain fatty acids impact on intestinal adaptation, inflammation, carcinoma and failure. Gastroenterology 130, S100\u2013105 (2006).","journal-title":"Gastroenterology"},{"key":"BFsrep08096_CR25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrmicro1817","volume":"6","author":"HJ Flint","year":"2008","unstructured":"Flint, H. J., Bayer, E. A., Rincon, M. T., Lamed, R. & White, B. A. Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis. Nat Rev Microbiol 6, 121\u2013131 (2008).","journal-title":"Nat Rev Microbiol"},{"key":"BFsrep08096_CR26","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1126\/science.1208344","volume":"334","author":"GD Wu","year":"2011","unstructured":"Wu, G. D. et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 334, 105\u2013108 (2011).","journal-title":"Science"},{"key":"BFsrep08096_CR27","doi-asserted-by":"publisher","first-page":"14691","DOI":"10.1073\/pnas.1005963107","volume":"107","author":"C De Filippo","year":"2010","unstructured":"De Filippo, C. et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A 107, 14691\u201314696 (2010).","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFsrep08096_CR28","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/oby.2008.55","volume":"16","author":"CS Kim","year":"2008","unstructured":"Kim, C. S. et al. Visceral fat accumulation induced by a high-fat diet causes the atrophy of mesenteric lymph nodes in obese mice. Obesity (Silver Spring) 16, 1261\u20131269 (2008).","journal-title":"Obesity (Silver Spring)"},{"key":"BFsrep08096_CR29","first-page":"631","volume":"17","author":"S Tanaka","year":"1993","unstructured":"Tanaka, S. et al. Impaired immunity in obesity: suppressed but reversible lymphocyte responsiveness. Int J Obes Relat Metab Disord 17, 631\u2013636 (1993).","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BFsrep08096_CR30","first-page":"347","volume":"54","author":"S Tanaka","year":"2001","unstructured":"Tanaka, S., Isoda, F., Ishihara, Y., Kimura, M. & Yamakawa, T. T lymphopaenia in relation to body mass index and TNF-alpha in human obesity: adequate weight reduction can be corrective. Clin Endocrinol (Oxf) 54, 347\u2013354 (2001).","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BFsrep08096_CR31","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1128\/iai.63.3.1122-1126.1995","volume":"63","author":"M Norimatsu","year":"1995","unstructured":"Norimatsu, M. et al. Lipopolysaccharide-induced apoptosis in swine lymphocytes in vivo. Infect Immun 63, 1122\u20131126 (1995).","journal-title":"Infect Immun"},{"key":"BFsrep08096_CR32","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1365-3083.2011.02613.x","volume":"75","author":"JS Nielsen","year":"2012","unstructured":"Nielsen, J. S. et al. Rough-Form-Lipopolysaccharide Increase Apoptosis in Human CD4(+) and CD8(+) T-Lymphocytes. Scand J Immunol 75, 193\u2013202 (2012).","journal-title":"Scand J Immunol"},{"key":"BFsrep08096_CR33","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","volume":"142","author":"N Chalasani","year":"2012","unstructured":"Chalasani, N. et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases and American College of Gastroenterology. Gastroenterology 142, 1592\u20131609 (2012).","journal-title":"Gastroenterology"},{"key":"BFsrep08096_CR34","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/labinvest.2012.12","volume":"92","author":"X Cong","year":"2012","unstructured":"Cong, X. et al. Activation of transient receptor potential vanilloid subtype 1 increases expression and permeability of tight junction in normal and hyposecretory submandibular gland. Lab Invest 92, 753\u2013768 (2012).","journal-title":"Lab Invest"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep08096","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep08096.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep08096.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T19:49:23Z","timestamp":1672948163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep08096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,3]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,7,15]]}},"alternative-id":["BFsrep08096"],"URL":"https:\/\/doi.org\/10.1038\/srep08096","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,3]]},"assertion":[{"value":"21 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8096"}}